| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.32B | 47.83B | 44.28B | 38.42B | 35.38B | 30.41B |
| Gross Profit | 12.73B | 11.95B | 13.72B | 11.66B | 9.04B | 6.59B |
| EBITDA | 14.53B | 12.68B | 15.04B | 13.85B | 10.41B | 8.09B |
| Net Income | 8.71B | 8.85B | 8.82B | 8.75B | 6.81B | 4.75B |
Balance Sheet | ||||||
| Total Assets | 94.62B | 91.06B | 92.34B | 88.47B | 78.52B | 62.77B |
| Cash, Cash Equivalents and Short-Term Investments | 26.52B | 25.67B | 22.31B | 19.89B | 17.58B | 12.72B |
| Total Debt | 18.87B | 11.48B | 17.35B | 15.44B | 13.12B | 4.44B |
| Total Liabilities | 29.76B | 23.90B | 29.67B | 28.18B | 24.05B | 13.84B |
| Stockholders Equity | 64.20B | 66.41B | 62.06B | 59.80B | 54.03B | 48.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.32B | 6.58B | 5.53B | 6.69B | 4.07B | -2.11B |
| Operating Cash Flow | 10.45B | 11.66B | 11.43B | 13.36B | 11.48B | 7.22B |
| Investing Cash Flow | -3.26B | -4.69B | -5.98B | -12.25B | -16.04B | -8.76B |
| Financing Cash Flow | -4.40B | -10.30B | -5.00B | -769.84M | 7.06B | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$47.30B | 11.05 | 9.96% | 6.39% | -8.51% | 9.94% | |
75 Outperform | HK$91.35B | ― | 7.60% | ― | 18.89% | 6.97% | |
74 Outperform | HK$131.04B | 11.17 | 14.02% | 3.05% | 16.03% | 1.30% | |
65 Neutral | HK$11.51B | 4.20 | 8.00% | 3.55% | -3.33% | -8.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$78.48B | 25.39 | 6.50% | ― | 18.42% | 97.52% | |
54 Neutral | HK$2.86B | 21.77 | 9.22% | 8.25% | -3.77% | -65.34% |